Antibiotic Prescribing by Dentists for Medicare Beneficiaries: Temporal Trends and Geographic Concentration in the United States
SAP Dentistry · 2026-08-21 · 4 · 257
DOI: 10.62486/dent2026257 ↗Abstract
Introduction: Dentists are a leading source of outpatient antibiotic prescriptions in the United States, yet their prescribing for Medicare beneficiaries is rarely described at national scale. Methods: This ecological time series analyzed the 2018 to 2023 files of the Medicare Part D Prescribers by Provider and Drug dataset, restricted to prescriber type dentist. Annual antibiotic claims, beneficiaries, agents and state-level volumes were tabulated and tested with Poisson and Cochran-Armitage trend models. Results: Dentists generated 4,450,465 antibiotic claims in 2018 and 5,780,560 in 2023 (increase of 29.9%; incidence rate ratio per year 1.058, 95% CI 1.057 to 1.058, p < 0.001), while the antibiotic share of dental claims remained stable (65.3% to 64.6%). Amoxicillin was the leading agent in every year, rising from 75.6% to 80.7% of antibiotic claims. The ten highest-volume states accounted for 56.5% of claims in 2023 (Gini coefficient 0.53). Conclusions: Antibiotic prescribing by dentists in Medicare Part D increased between 2018 and 2023, was dominated by amoxicillin and remained concentrated in a minority of states, which identifies concrete targets for dental antimicrobial stewardship.
EUVIMED